Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pretransplant Thymoglobulin in Living Donor Renal Transplant
NCT00771745Phase 4Completed
- Sponsor
- University of Cincinnati
- Start
- Sep 2008
- Primary completion
- Jun 2010
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of antithymocyte globulin in renal transplant rejection (RTR), sponsored by University of Cincinnati. Started Sep 2008; status: completed.
02
Drugs
antithymocyte globulin
03
Conditions
renal transplant rejection (RTR)
Beyond the preview
Go deeper on NCT00771745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00771745.